SCG10 is a JNK target in the axonal degeneration pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 52, 2012, Pages

  Shin, Jung Eun ^a   Miller, Bradley R ^a,b,c   Babetto, Elisabetta ^a   Cho, Yongcheol ^a   Sasaki, Yo ^a   Qayum, Shehzad ^a   Russler, Emilie V ^a   Cavalli, Valeria ^a   Milbrandt, Jeffrey ^a   DiAntonio, Aaron ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE PROTEIN; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; SUPERIOR CERVICAL GANGLION 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; MOUSE; NERVE FIBER DEGENERATION; NERVE FIBER TRANSECTION; NERVE FIBER TRANSPORT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SCIATIC NERVE INJURY; SIGNAL TRANSDUCTION; SPINAL GANGLION; SUPERIOR CERVICAL GANGLION;

ANIMALS; AXONS; BIOLOGICAL MARKERS; GENE KNOCKDOWN TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NERVE DEGENERATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; PROTEOLYSIS; RATS;

EID: 84871834042     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216204109     Document Type: Article

References (50)

1. Coleman MP, Perry VH (2002) Axon pathology in neurological disease: A neglected therapeutic target. Trends Neurosci 25(10):532-537. (Pubitemid 35246324)
2. Luo L, O'Leary DD (2005) Axon retraction and degeneration in development and disease. Annu Rev Neurosci 28:127-156. (Pubitemid 41098902)
3. Rosenthal S, Kaufman S (1974) Vincristine neurotoxicity. Ann Intern Med 80(6):733-737.
4. Höke A (2006) Neuroprotection in the peripheral nervous system: Rationale for more effective therapies. Arch Neurol 63(12):1681-1685.
5. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305(5686):1010-1013. (Pubitemid 39071777)
6. Avery MA, Sheehan AE, Kerr KS, Wang J, Freeman MR (2009) Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol 184(4):501-513.
7. Conforti L, et al. (2000) A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci USA 97(21):11377-11382.
8. Conforti L, et al. (2009) Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184(4):491-500.
9. Mack TG, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4(12):1199-1206. (Pubitemid 33135625)
10. Wang JT, Medress ZA, Barres BA (2012) Axon degeneration: Molecular mechanisms of a self-destruction pathway. J Cell Biol 196(1):7-18.
11. Zhai Q, et al. (2003) Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39(2):217-225. (Pubitemid 36897545)
12. Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8(1):e1000300.
13. Barnat M, et al. (2010) Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. J Neurosci 30(23):7804-7816.
14. Kenney AM, Kocsis JD (1998) Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo. J Neurosci 18(4):1318-1328. (Pubitemid 28082417)
15. Lindwall C, Dahlin L, Lundborg G, Kanje M (2004) Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol Cell Neurosci 27(3):267-279. (Pubitemid 39433841)
16. Miller BR, et al. (2009) A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat Neurosci 12(4):387-389.
17. Nix P, Hisamoto N, Matsumoto K, Bastiani M (2011) Axon regeneration requires coordinate activation of p38 and JNK MAPK pathways. Proc Natl Acad Sci USA 108 (26):10738-10743.
18. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270(5240):1326-1331.
19. Xiong X, Collins CA (2012) A conditioning lesion protects axons from degeneration via the Wallenda/DLK MAP kinase signaling cascade. J Neurosci 32(2):610-615.
20. Xiong X, et al. (2010) Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury. J Cell Biol 191(1):211-223.
21. Yoshimura K, et al. (2011) c-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice. Neurosci Res 71(3):266-277.
22. Tararuk T, et al. (2006) JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol 173(2):265-277.
23. Riederer BM, et al. (1997) Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10. Proc Natl Acad Sci USA 94(2):741-745. (Pubitemid 27053704)
24. Antonsson B, et al. (1998) Identification of in vitro phosphorylation sites in the growth cone protein SCG10. Effect Of phosphorylation site mutants on microtubule-destabilizing activity. J Biol Chem 273(14):8439-8446. (Pubitemid 28168907)
25. Sasaki Y, Araki T, Milbrandt J (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 26(33):8484-8491. (Pubitemid 44316176)
26. Beirowski B, et al. (2005) The progressive nature of Wallerian degeneration in wildtype and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 6:6.
27. Chao DT, et al. (1995) Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182(3):821-828.
28. Gerdts J, Sasaki Y, Vohra B, Marasa J, Milbrandt J (2011) Image-based screening identifies novel roles for IkappaB kinase and glycogen synthase kinase 3 in axonal degeneration. J Biol Chem 286(32):28011-28018.
29. Vohra BP, et al. (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J Neurosci 30(41):13729-13738.
30. Sasaki Y, Vohra BP, Lund FE, Milbrandt J (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29(17):5525-5535.
31. Coleman MP, Freeman MR (2010) Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 33:245-267.
32. Court FA, Coleman MP (2012) Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci 35(6):364-372.
33. De Vos KJ, Grierson AJ, Ackerley S, Miller CC (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31:151-173.
34. Avery MA, et al. (2012) WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr Biol 22(7):596-600.
35. Barrientos SA, et al. (2011) Axonal degeneration is mediated by the mitochondrial permeability transition pore. J Neurosci 31(3):966-978.
36. Hunter T (2007) The age of crosstalk: Phosphorylation, ubiquitination, and beyond. Mol Cell 28(5):730-738.
37. Vega IE, Hamano T, Propost JA, Grenningloh G, Yen SH (2006) Taxol and tau overexpression induced calpain-dependent degradation of the microtubule-destabilizing protein SCG10. Exp Neurol 202(1):152-160. (Pubitemid 44376594)
38. Camoletto P, Colesanti A, Ozon S, Sobel A, Fasolo A (2001) Expression of stathmin and SCG10 proteins in the olfactory neurogenesis during development and after lesion in the adulthood. Brain Res Bull 54(1):19-28. (Pubitemid 32156913)
39. Pellier-Monnin V, Astic L, Bichet S, Riederer BM, Grenningloh G (2001) Expression of SCG10 and stathmin proteins in the rat olfactory system during development and axonal regeneration. J Comp Neurol 433(2):239-254. (Pubitemid 32280976)
40. Voria I, et al. (2006) Improved sciatic nerve regeneration by local thyroid hormone treatment in adult rat is accompanied by increased expression of SCG10. Exp Neurol 197(1):258-267. (Pubitemid 41817238)
41. Li YH, et al. (2009) Rnd1 regulates axon extension by enhancing the microtubule destabilizing activity of SCG10. J Biol Chem 284(1):363-371.
42. Morii H, Shiraishi-Yamaguchi Y, Mori N (2006) SCG10, a microtubule destabilizing factor, stimulates the neurite outgrowth by modulating microtubule dynamics in rat hippocampal primary cultured neurons. J Neurobiol 66(10):1101-1114. (Pubitemid 44264934)
43. Xu H, Dhanasekaran DN, Lee CM, Reddy EP (2010) Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. J Biol Chem 285(6):3548-3553.
44. Carmichael ST, et al. (2005) Growth-associated gene expression after stroke: Evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol 193(2):291-311. (Pubitemid 40616180)
45. Mason MR, Lieberman AR, Grenningloh G, Anderson PN (2002) Transcriptional upregulation of SCG10 and CAP-23 is correlated with regeneration of the axons of peripheral and central neurons in vivo. Mol Cell Neurosci 20(4):595-615.
46. Shin JE, et al. (2012) Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration. Neuron 74(6):1015-1022.
47. Lipton RB, et al. (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39(3):368-373. (Pubitemid 19094727)
48. Cortes J, Baselga J (2007) Targeting the microtubules in breast cancer beyond taxanes: The epothilones. Oncologist 12(3):271-280. (Pubitemid 46556793)
49. Graf ER, Heerssen HM, Wright CM, Davis GW, DiAntonio A (2011) Stathmin is required for stability of the Drosophila neuromuscular junction. J Neurosci 31(42):15026-15034.
50. Ozon S, Maucuer A, Sobel A (1997) The stathmin family - molecular and biological characterization of novel mammalian proteins expressed in the nervous system. Eur J Biochem 248(3):794-806. (Pubitemid 27400034)